Answer
Treatment-emergent Grade 3 or 4 cytopenias, including neutropenia, anaemia and thrombocytopenia, have occurred in patients with haematologic malignancies receiving Calquence (acalabrutinib maleate) alone or with other medicinal products.
Sources for this answer
- Calquence 100 mg film-coated tabletsAstraZeneca UK Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 8Document updated
Sources checked